Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,371.00
Bid: 2,368.00
Ask: 2,370.00
Change: 22.00 (0.94%)
Spread: 2.00 (0.084%)
Open: 2,358.00
High: 2,377.00
Low: 2,351.00
Prev. Close: 2,349.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US Bond Issue by B.A.T Capital Corporation

9 Aug 2017 09:33

RNS Number : 5099N
British American Tobacco PLC
09 August 2017
 

US Bond Issue

 

B.A.T Capital Corporation announces that it has successfully priced a US dollar denominated issue of notes (the "Notes"), raising proceeds of approximately $17.25 billion. The Notes will be issued by B.A.T Capital Corporation and guaranteed by British American Tobacco p.l.c., British American Tobacco Holdings (The Netherlands) B.V., B.A.T. Netherlands Finance B.V., B.A.T. International Finance p.l.c. and Reynolds American Inc. pursuant to Rule 144A and Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act"), in eight tranches:

$2,250,000,000 2.297 per cent Notes due 2020;

$2,250,000,000 2.764 per cent Notes due 2022;

$2,500,000,000 3.222 per cent Notes due 2024;

$3,500,000,000 3.557 per cent Notes due 2027;

$2,500,000,000 4.390 per cent Notes due 2037;

$2,500,000,000 4.540 per cent Notes due 2047;

$1,000,000,000 Floating Rate Notes due 2020; and

$750,000,000 Floating Rate Notes due 2022.

It is expected that the net proceeds of the offering will be used to repay a portion of the amounts outstanding under the acquisition facility borrowed in relation to the merger of the British American Tobacco group and Reynolds American Inc., to pay merger related fees and expenses, and for general corporate purposes, which may include the repayment of certain outstanding debt. The issue is scheduled to close on 15 August 2017, subject to customary conditions.

It is expected that listing particulars in respect of the Notes will shortly be filed with the UK Listing Authority.

The Notes have not been registered under the Securities Act, or under the securities legislation of any states of the United States, and may not be offered or sold in the United States, absent registration or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

This announcement does not constitute or form part of any offer or any solicitation to purchase nor shall it, or the fact of its distribution, form the basis of, or be relied on in any purchase. This announcement and any subsequent offer of securities may be restricted by law in certain jurisdictions and persons receiving this announcement or any subsequent offer should inform themselves about and observe any such restriction. Failure to comply with such restrictions may violate securities laws of any such jurisdiction.

 

Enquiries

 

 

Investor Relations 

Mike Nightingale/Rachael Brierley/Sabina Marshman

+44 (0)20 7845 1180/1519/1781

British American Tobacco Press Office 

+44 (0)20 7845 2888 (24 hours)│@BATPress

 

British American Tobacco p.l.c.

Globe House

4 Temple Place

London WC2R 2PG

 

09 August 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUKUWRBNAWRRR
Date   Source Headline
13th Nov 20233:00 pmRNSDirector/PDMR Shareholding
13th Nov 20232:15 pmRNSDirector/PDMR Shareholding
8th Nov 20239:55 amRNSDirector/PDMR Shareholding
8th Nov 20239:50 amRNSDirector/PDMR Shareholding
8th Nov 20239:45 amRNSDirector/PDMR Shareholding
2nd Nov 20231:15 pmRNSDirector/PDMR Shareholding
2nd Nov 20237:00 amRNSBAT Appoints Chief Financial Officer
1st Nov 202312:10 pmRNSTotal Voting Rights
13th Oct 20237:00 amRNSBAT Appoints Chief People Officer
5th Oct 20231:00 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSDirectorate Change
2nd Oct 20231:40 pmRNSTotal Voting Rights
26th Sep 20232:40 pmRNSDirector/PDMR Shareholding
18th Sep 20237:00 amRNSBranch Register: Dividend Finalisation Information
14th Sep 20239:00 amRNSRussia business update - sale completed
12th Sep 20233:05 pmRNSDirector/PDMR Shareholding
7th Sep 20231:15 pmRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSRussia business update – agreement signed
1st Sep 202310:30 amRNSTotal Voting Rights
24th Aug 20233:40 pmRNSDirector/PDMR Shareholding
22nd Aug 20234:50 pmRNSDirector/PDMR Shareholding
22nd Aug 20233:50 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:25 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:20 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:15 pmRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSCompany Secretary Change
14th Aug 20234:53 pmRNSTender Offer Pricing
14th Aug 202311:30 amRNSResult of Tender Offer
3rd Aug 20233:30 pmRNSDirector/PDMR Shareholding
3rd Aug 202310:20 amRNSPublication of Supplementary Prospectus
1st Aug 202311:38 amRNSPricing Notes Offering
1st Aug 202310:35 amRNSTotal Voting Rights
31st Jul 20231:26 pmRNSTender Offer
26th Jul 20237:00 amRNSHalf-year Report
6th Jul 20233:00 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSBranch Register: Dividend Finalisation Information
3rd Jul 20231:40 pmRNSBlock listing Interim Review
3rd Jul 20231:30 pmRNSTotal Voting Rights
20th Jun 202311:00 amRNSDirector/PDMR Shareholding
19th Jun 20237:00 amRNSManagement Board Changes
8th Jun 202312:45 pmRNSDirector/PDMR Shareholding
6th Jun 202310:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNS2023 First Half Pre-Close Trading Update
1st Jun 202311:00 amRNSTotal Voting Rights
31st May 202310:45 amRNSDirector/PDMR Shareholding
24th May 20234:35 pmRNSDirector/PDMR Shareholding
22nd May 20232:00 pmRNSHolding(s) in Company
15th May 20237:00 amRNSBAT announces Tadeu Marroco as Chief Executive
12th May 20234:45 pmRNSDirector/PDMR Shareholding
12th May 202312:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.